600085 同仁堂
交易中 12-18 13:48:37
资讯
新帖
简况
中金公司合并东兴、信达预案出炉；美克家居拟收购深圳万德溙控制权；同仁堂澄清不存在委托外部第三方生产药品情况｜公告精选
每日经济新闻 · 12-17 23:52
中金公司合并东兴、信达预案出炉；美克家居拟收购深圳万德溙控制权；同仁堂澄清不存在委托外部第三方生产药品情况｜公告精选
同仁堂（600085）披露关于相关媒体报道的澄清公告，12月17日股价下跌0.82%
证券之星 · 12-17 22:27
同仁堂（600085）披露关于相关媒体报道的澄清公告，12月17日股价下跌0.82%
同仁堂最新公告：未直接或间接持有南极磷虾油相关报道中提及的四川健康药业任何股权及投资权益
证券之星 · 12-17 18:49
同仁堂最新公告：未直接或间接持有南极磷虾油相关报道中提及的四川健康药业任何股权及投资权益
同仁堂“造假门”背后的品牌之困：贴牌乱象与业绩下滑的双重挑战
新浪证券 · 12-17 15:05
同仁堂“造假门”背后的品牌之困：贴牌乱象与业绩下滑的双重挑战
主要成分含量为0！推脱责任、涉嫌故意造假，同仁堂被约谈
中国基金报 · 12-17 06:18
主要成分含量为0！推脱责任、涉嫌故意造假，同仁堂被约谈
同仁堂产品涉嫌造假？官方回应：责令停止经销该产品，将起诉涉事企业
新浪财经 · 12-15 19:52
同仁堂产品涉嫌造假？官方回应：责令停止经销该产品，将起诉涉事企业
同仁堂回应磷虾油涉嫌造假：对涉事产品开展全流程核查与追溯
视频滚动新闻 · 12-15 17:54
同仁堂回应磷虾油涉嫌造假：对涉事产品开展全流程核查与追溯
涉嫌造假，同仁堂被约谈
深蓝财经 · 12-14
涉嫌造假，同仁堂被约谈
磷虾油磷脂含量实测为0！北京同仁堂涉嫌造假，企业将被约谈
南方都市报 · 12-11
磷虾油磷脂含量实测为0！北京同仁堂涉嫌造假，企业将被约谈
同仁堂：获得加拿大产品许可证
南方财经网 · 12-08
同仁堂：获得加拿大产品许可证
阿里健康与北京同仁堂达成战略合作 百年名药拥抱数字服务新生态
金融界 · 12-04
阿里健康与北京同仁堂达成战略合作 百年名药拥抱数字服务新生态
北京同仁堂控股孙公司国药将支付品牌使用费
中金财经 · 11-29
北京同仁堂控股孙公司国药将支付品牌使用费
同仁堂国药(03613.HK)与同仁堂集团订立新商标许可框架协议
格隆汇 · 11-28
同仁堂国药(03613.HK)与同仁堂集团订立新商标许可框架协议
同仁堂(600085.SH)：麻仁润肠丸获加拿大产品注册
智通财经 · 11-07
同仁堂(600085.SH)：麻仁润肠丸获加拿大产品注册
同仁堂（600085）2025年三季报简析：净利润同比下降12.78%
证券之星 · 11-01
同仁堂（600085）2025年三季报简析：净利润同比下降12.78%
同仁堂(600085)9月30日股东户数13.22万户，较上期增加21.16%
证券之星 · 10-30
同仁堂(600085)9月30日股东户数13.22万户，较上期增加21.16%
同仁堂(600085.SH)发布前三季度业绩，归母净利润11.78亿元，下降12.78%
智通财经 · 10-30
同仁堂(600085.SH)发布前三季度业绩，归母净利润11.78亿元，下降12.78%
同仁堂医养上市聆讯获通过 拟于港交所主板上市
中国上市公司网 · 10-09
同仁堂医养上市聆讯获通过 拟于港交所主板上市
同仁堂新注册《沉浸式裸眼3D展示系统V1.0》项目的软件著作权
证券之星 · 10-02
同仁堂新注册《沉浸式裸眼3D展示系统V1.0》项目的软件著作权
同仁堂新注册《中药材互动式智慧科普系统V1.0》项目的软件著作权
证券之星 · 09-30
同仁堂新注册《中药材互动式智慧科普系统V1.0》项目的软件著作权
公司概况
公司名称：
北京同仁堂股份有限公司
所属行业：
医药制造业
上市日期：
1997-06-25
主营业务：
北京同仁堂股份有限公司的主营业务是中成药的生产与销售。公司的主要产品是安宫牛黄丸、同仁牛黄清心丸、同仁大活络丸、六味地黄丸，金匮肾气。公司“中药制造测量学关键技术与标准及软件装备应用项目”荣获中国产学研合作创新与促进奖。
发行价格：
7.08
{"stockData":{"symbol":"600085","market":"SH","secType":"STK","nameCN":"同仁堂","latestPrice":32.45,"timestamp":1766036917000,"preClose":32.57,"halted":0,"volume":3970798,"delay":0,"changeRate":-0.0037,"floatShares":1371000000,"shares":1371000000,"eps":0.9871,"marketStatus":"交易中","change":-0.12,"latestTime":"12-18 13:48:37","open":32.56,"high":32.75,"low":32.34,"amount":129000000,"amplitude":0.0126,"askPrice":32.45,"askSize":61,"bidPrice":32.44,"bidSize":175,"shortable":0,"etf":0,"ttmEps":0.9871,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766041200000},"marketStatusCode":2,"adr":0,"adjPreClose":32.57,"symbolType":"stock","openAndCloseTimeList":[[1766021400000,1766028600000],[1766034000000,1766041200000]],"highLimit":35.83,"lowLimit":29.31,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1371470262,"isCdr":false,"pbRate":3.27,"roa":"--","peRate":32.874076,"roe":"8.72%","epsLYR":1.113,"committee":0.180328,"marketValue":44504000000,"turnoverRate":0.0029,"status":1,"floatMarketCap":44504000000},"requestUrl":"/m/hq/s/600085/wiki","defaultTab":"wiki","newsList":[{"id":"2592791162","title":"中金公司合并东兴、信达预案出炉；美克家居拟收购深圳万德溙控制权；同仁堂澄清不存在委托外部第三方生产药品情况｜公告精选","url":"https://stock-news.laohu8.com/highlight/detail?id=2592791162","media":"每日经济新闻","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592791162?lang=zh_cn&edition=full","pubTime":"2025-12-17 23:52","pubTimestamp":1765986754,"startTime":"0","endTime":"0","summary":"股份收购美克家居：拟收购深圳万德溙控制权美克家居公告，公司正在筹划通过发行股份及支付现金的方式收购深圳万德溙光电科技有限公司控制权，并募集配套资金。本次交易尚处于筹划阶段。公司股票自12月18日开市起开始停牌，预计停牌时间不超过10个交易日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512173594572210.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512173594572210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0183","BK0276","BK1501","LU0359201885.HKD","LU1580142542.USD","BK1564","601995","BK0113","BK0188","BK0209","BK0028","LU1023057109.AUD","BK0196","03908","LU1508157978.USD","LU0359201612.USD","LU2663582299.SGD","BK0086","LU1781817850.SGD","LU1688375341.USD","BK0012","BK0097","600085","BK1147","BK1516","600337","BK0239","LU0359202008.SGD","SG9999002828.SGD","BK0070"],"gpt_icon":0},{"id":"2592915221","title":"同仁堂（600085）披露关于相关媒体报道的澄清公告，12月17日股价下跌0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592915221","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592915221?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:27","pubTimestamp":1765981621,"startTime":"0","endTime":"0","summary":"截至2025年12月17日收盘，同仁堂报收于32.57元，较前一交易日下跌0.82%，最新总市值为446.69亿元。该股当日开盘32.79元，最高32.79元，最低32.3元，成交额达2.19亿元，换手率为0.49%。公司近日发布《关于相关媒体报道的澄清公告》，就媒体报道涉及安徽哈博药业生产、北京同仁堂（四川）健康药业有限公司经销的南极磷虾油产品一事作出说明。同仁堂商标及字号所有权归同仁堂集团所有，公司仅获授权使用。公司已与同仁堂集团进行沟通，双方将共同维护品牌形象。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700039849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","BK0097","BK0113","LU1688375341.USD","BK0086","BK0012","BK0239","600085","BK0183","BK0028"],"gpt_icon":0},{"id":"2592499978","title":"同仁堂最新公告：未直接或间接持有南极磷虾油相关报道中提及的四川健康药业任何股权及投资权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2592499978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592499978?lang=zh_cn&edition=full","pubTime":"2025-12-17 18:49","pubTimestamp":1765968583,"startTime":"0","endTime":"0","summary":"同仁堂(600085.SH)公告称，关注到网络上有关安徽哈博药业有限公司生产、北京同仁堂（四川）健康药业有限公司经销的南极磷虾油产品及相关对“同仁堂”品牌的报道。公司未直接或间接持有四川健康药业任何股权及投资权益，四川健康药业不属于公司下属子企业。四川健康药业为公司控股股下属同仁堂健康的控股子公司。截至本公告披露日，本公司药品均为自主生产，不存在委托外部第三方生产的情况。公司生产经营正常，将积极采取一切措施，维护老字号品牌权益。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700030346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0239","BK0028","LU1688375341.USD","BK0188","BK0196","BK0012","BK0113","BK0097","600085","BK0086"],"gpt_icon":0},{"id":"2592961021","title":"同仁堂“造假门”背后的品牌之困：贴牌乱象与业绩下滑的双重挑战","url":"https://stock-news.laohu8.com/highlight/detail?id=2592961021","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592961021?lang=zh_cn&edition=full","pubTime":"2025-12-17 15:05","pubTimestamp":1765955100,"startTime":"0","endTime":"0","summary":"百年老字号同仁堂，近日因一款“南极磷虾油”产品被推上舆论风口。上海市消保委检测发现，该产品标识磷脂含量43%，实际检测结果为0，涉嫌虚假宣传。然而，同仁堂集团却回应称“没有这款产品”。一场“造假”罗生门的背后，折射出这家药界老字号在品牌管控、业绩压力与治理结构上的多重风险。“贴牌乱象”侵蚀信任根基","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-12-17/doc-inhcavhm7557920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0086","600085","BK0028","BK0113","LU1688375341.USD","BK0239","BK0183","BK0196","BK0097","BK0188","BK0012"],"gpt_icon":0},{"id":"2592952127","title":"主要成分含量为0！推脱责任、涉嫌故意造假，同仁堂被约谈","url":"https://stock-news.laohu8.com/highlight/detail?id=2592952127","media":"中国基金报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592952127?lang=zh_cn&edition=full","pubTime":"2025-12-17 06:18","pubTimestamp":1765923532,"startTime":"0","endTime":"0","summary":"12月15日下午，上海市消保委针对北京同仁堂南极磷虾油产品的相关问题，约谈了该产品的经销商与生产商。经销商北京同仁堂（四川）健康药业有限公司在约谈中回避问题推脱责任，声称对产品的涉嫌造假行为毫不知情，与己无关。上海市消保委经过大量调查，认为涉事企业存在涉嫌故意造假行为，既侵犯消费者合法权益，也违反市场经营诚信原则。北京同仁堂健康药业股份有限公司持股51%，两名自然人持有其余49%的股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fenghuang_stock","url":"https://finance.ifeng.com/c/8p9IPWEVA7J","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.ifeng.com/c/8p9IPWEVA7J","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK0196","BK0188","BK0097","BK0113","LU1688375341.USD","BK0086","BK0012","BK0239","600085","BK0183","BK0028"],"gpt_icon":0},{"id":"2591645159","title":"同仁堂产品涉嫌造假？官方回应：责令停止经销该产品，将起诉涉事企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2591645159","media":"新浪财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591645159?lang=zh_cn&edition=full","pubTime":"2025-12-15 19:52","pubTimestamp":1765799520,"startTime":"0","endTime":"0","summary":" 12月15日，同仁堂健康发布声明称，近日，有媒体报道一款标注“安徽哈博药业有限公司生产、北京同仁堂（四川）健康药业有限公司经销”的“99%高纯南极磷虾油”产品，相关成分涉嫌虚假标注。针对上述情况，公司立即责令四川健康药业停止经销该产品，并对涉事产品开展全流程核查与追溯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-15/doc-inhawtsc1869926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0113","BK0188","BK0028","LU1688375341.USD","BK0183","BK0196","BK0097","BK0086","BK0012","600085"],"gpt_icon":0},{"id":"2591617186","title":"同仁堂回应磷虾油涉嫌造假：对涉事产品开展全流程核查与追溯","url":"https://stock-news.laohu8.com/highlight/detail?id=2591617186","media":"视频滚动新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591617186?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:54","pubTimestamp":1765792440,"startTime":"0","endTime":"0","summary":"12月15日，“同仁堂健康会员”微信公众号发布声明称，有媒体报道一款标注“安徽哈博药业有限公司生产、北京同仁堂（四川）健康药业有限公司（以下简称‘四川健康药业’）经销”的“99%高纯南极磷虾油”产品，相关成分涉嫌虚假标注。针对上述情况，公司立即责令四川健康药业停止经销该产品，并对涉事产品开展全流程核查与追溯。同仁堂在声明中表示，这款产品未经授权擅自突出使用“北京同仁堂”字样，涉嫌违法，公司已启动司法程序，对涉事企业进行起诉。（界面）\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：小浪快报","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/videoroll/2025-12-15/doc-inhawpkc2320207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0113","BK0188","BK0028","LU1688375341.USD","BK0183","BK0196","BK0097","BK0086","BK0012","600085"],"gpt_icon":0},{"id":"2591669239","title":"涉嫌造假，同仁堂被约谈","url":"https://stock-news.laohu8.com/highlight/detail?id=2591669239","media":"深蓝财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591669239?lang=zh_cn&edition=full","pubTime":"2025-12-14 18:41","pubTimestamp":1765708860,"startTime":"0","endTime":"0","summary":"针对相关企业涉嫌造假行为，为了保护消费者合法权益，上海市消保委将于近日约谈该产品的生产企业安徽哈博药业有限公司和经销商北京同仁堂（四川）健康药业有限公司，要求其对产品的真实情况做出解释。电商平台截图12月12日，同仁堂四川公司相关工作人员称，已经和上海消保委进行了沟通，进一步核实相关的检测结果。这位工作人员表示，从今年6月份开始，“北京同仁堂99%高纯南极磷虾油”已经停产，市面上销售的大多是分销商的存货。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU1Njc1NjA2NA==&mid=2247593521&idx=1&sn=2b04910f68f0a9e5041d8030b8c127bb&chksm=fae28bb25f5eb8d0769c000f8061b23789e56cd3e504eba48e658eb0aebd540189253e140fb5&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK0028","BK0196","BK0113","BK0086","BK0239","600085","BK0188","BK0183","LU1688375341.USD","BK0097","BK0012"],"gpt_icon":0},{"id":"2590513269","title":"磷虾油磷脂含量实测为0！北京同仁堂涉嫌造假，企业将被约谈","url":"https://stock-news.laohu8.com/highlight/detail?id=2590513269","media":"南方都市报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590513269?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:20","pubTimestamp":1765455626,"startTime":"0","endTime":"0","summary":"12月11日，上海消保委发布了15款不同品牌的南极磷虾油产品比较检测结果。结果显示，其中一款由安徽哈博药业有限公司所生产的，标称为“北京同仁堂99%高纯南极磷虾油”的产品，其磷脂标识值为43%，但检测结果显示该款产品磷脂含量为0。对于该情况，上海消保委认为相关企业涉嫌造假行为，并将于近日约谈该产品的生产企业安徽哈博药业有限公司和经销商北京同仁堂（四川）健康药业有限公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512113589086776.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0196","600085","BK0239","BK0183","BK0188","LU1688375341.USD","BK0086","BK0012","BK0097","BK0113","BK0028"],"gpt_icon":0},{"id":"2589333048","title":"同仁堂：获得加拿大产品许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2589333048","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589333048?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:55","pubTimestamp":1765184136,"startTime":"0","endTime":"0","summary":"南财智讯12月8日电，同仁堂公告，公司分支机构北京同仁堂股份有限公司同仁堂制药厂收到加拿大卫生部核准签发的《产品许可证（三类）》，同仁堂制药厂产品参苓白术散获得加拿大产品注册。该产品取得上市许可，但后续若拟在加拿大销售，还需完成包括生产场地的加拿大生产质量体系认证等行政审批事项，存在不确定性。本次获批对公司近期经营业绩不会产生重大影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512083585343473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0028","BK0196","BK0113","BK0086","BK0239","600085","BK0188","BK0183","LU1688375341.USD","BK0097","BK0012"],"gpt_icon":0},{"id":"2588888883","title":"阿里健康与北京同仁堂达成战略合作 百年名药拥抱数字服务新生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2588888883","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588888883?lang=zh_cn&edition=full","pubTime":"2025-12-04 18:15","pubTimestamp":1764843338,"startTime":"0","endTime":"0","summary":"12月4日，阿里健康与中华老字号品牌北京同仁堂达成战略合作。同仁堂安宫牛黄丸：百年传承的急救经典同仁堂的安宫牛黄丸，有文字记载的传承至今已有150多年。面对脑卒中防治的严峻形势，传统医疗模式在满足患者全周期健康管理需求方面已显不足，为提升年轻群体对传统中药的认知与应用普及，阿里健康与北京同仁堂达成战略合作。","market":"hk","thumbnail":"http://imgcloud.jrjimg.cn/2025/12/04/bd0f1a799d4c06c6618159b6dcf1a009.jpeg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2025/12/04/bd0f1a799d4c06c6618159b6dcf1a009.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2025/12/04181554574988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1501","BK1571","BK1189","BK0188","BK1610","BK0113","BK1142","BK0196","BK0086","BK0183","BK1591","00241","BK0028","BK1584","BK1615","BK0239","BK0012","BK1589","BK0097","600085","LU1688375341.USD","BK1502","BK1247","BK1515","BK1617"],"gpt_icon":0},{"id":"2587076879","title":"北京同仁堂控股孙公司国药将支付品牌使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=2587076879","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587076879?lang=zh_cn&edition=full","pubTime":"2025-11-29 19:42","pubTimestamp":1764416523,"startTime":"0","endTime":"0","summary":"中访网数据 北京同仁堂股份有限公司公告，其控股孙公司北京同仁堂国药有限公司拟与控股股东中国北京同仁堂(集团)有限责任公司签订新的《“同仁堂”品牌使用许可框架协议》，协议期限为两年，自2026年1月1日起至2027年12月31日。同时，公司控股子公司北京同仁堂科技发展股份有限公司拟与同仁堂集团签署补充协议，修订其此前协议中关于同仁堂国药等境外公司豁免收费的条款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251129/31833784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["600085","LU1688375341.USD","BK0196","BK0028","BK0183","BK0188","BK0097","BK0012","BK0113","BK0086","BK0239"],"gpt_icon":0},{"id":"2586783729","title":"同仁堂国药(03613.HK)与同仁堂集团订立新商标许可框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2586783729","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586783729?lang=zh_cn&edition=full","pubTime":"2025-11-28 17:54","pubTimestamp":1764323645,"startTime":"0","endTime":"0","summary":"格隆汇11月28日丨同仁堂国药(03613.HK)公告，内容有关(其中包括)与同仁堂集团公司于2013年4月15日订立现有商标许可协议，据此，公司无须就使用同仁堂集团公司商标缴付任何费用或收费。经订约方一致同意，现有商标许可协议将于2025年12月31日终止。公司与同仁堂集团公司于2025年11月28日订立新商标许可框架协议。据此，同仁堂集团公司同意允许集团使用同仁堂集团公司的“同仁堂”字号及部分商标，期限自2026年1月1日至2027年12月31日止。\n\n港股频道更多独家策划、专家专栏，免费查阅>>\n\r\n 责任编辑：山上","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2025/11/28175454467318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0012","BK0239","BK0028","600085","BK0196","LU1688375341.USD","BK1191","03613","BK0113","BK1606","BK0097","BK0086","BK0188","BK0183"],"gpt_icon":0},{"id":"2581071267","title":"同仁堂(600085.SH)：麻仁润肠丸获加拿大产品注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2581071267","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581071267?lang=zh_cn&edition=full","pubTime":"2025-11-07 15:41","pubTimestamp":1762501308,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同仁堂(600085.SH)公告，公司分支机构北京同仁堂股份有限公司同仁堂制药厂(简称同仁堂制药厂)收到加拿大卫生部核准签发的《产品许可证(三类)》，同仁堂制药厂产品麻仁润肠丸获得加拿大产品注册。适应症为：传统中医理论的药物/产品制剂。用于缓解肠胃积热引起的胸腹胀满，大便秘结。传统中药用于润肠通便。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366521.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0183","BK0239","600085","BK0113","LU1688375341.USD","BK0188","BK0012","BK0196","BK0097","BK0028","BK0086"],"gpt_icon":0},{"id":"2580441419","title":"同仁堂（600085）2025年三季报简析：净利润同比下降12.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580441419","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580441419?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:03","pubTimestamp":1761948229,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期同仁堂发布2025年三季报。根据财报显示，同仁堂净利润同比下降12.78%。截至本报告期末，公司营业总收入133.08亿元，同比下降3.7%，归母净利润11.78亿元，同比下降12.78%。按单季度数据看，第三季度营业总收入35.39亿元，同比下降12.76%，第三季度归母净利润2.32亿元，同比下降29.49%。持有同仁堂最多的基金为汇添富中证中药ETF，目前规模为24.89亿元，最新净值1.0839，较上一交易日上涨1.5%，近一年下跌4.28%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100005194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600085"],"gpt_icon":0},{"id":"2579190353","title":"同仁堂(600085)9月30日股东户数13.22万户，较上期增加21.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579190353","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579190353?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:12","pubTimestamp":1761815542,"startTime":"0","endTime":"0","summary":"证券之星消息，近日同仁堂披露，截至2025年9月30日公司股东户数为13.22万户，较6月30日增加2.31万户，增幅为21.16%。在中药行业个股中，同仁堂股东户数高于行业平均水平，截至9月30日，中药行业平均股东户数为5.35万户。从股价来看，2025年6月30日至2025年9月30日，同仁堂区间跌幅为5.66%，在此期间股东户数增加2.31万户，增幅为21.16%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000031766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","600085","BK0183","BK0097","BK0086","BK0028","BK0113","BK0188","BK0239","LU1688375341.USD","BK0196"],"gpt_icon":0},{"id":"2579199861","title":"同仁堂(600085.SH)发布前三季度业绩，归母净利润11.78亿元，下降12.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579199861","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579199861?lang=zh_cn&edition=full","pubTime":"2025-10-30 15:40","pubTimestamp":1761810015,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同仁堂(600085.SH)发布2025年三季度报告，该公司前三季度营业收入为133.08亿元，同比减少3.70%。归属于上市公司股东的净利润为11.78亿元，同比减少12.78%。归属于上市公司股东的扣除非经常性损益的净利润为11.63亿元，同比减少11.95%。基本每股收益为0.859元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"同仁堂(600085.SH)发布前三季度业绩，归母净利润11.78亿元，下降12.78%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600085"],"gpt_icon":0},{"id":"2574063182","title":"同仁堂医养上市聆讯获通过 拟于港交所主板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2574063182","media":"中国上市公司网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574063182?lang=zh_cn&edition=full","pubTime":"2025-10-09 13:46","pubTimestamp":1759988760,"startTime":"0","endTime":"0","summary":"中国上市公司网讯 9月30日，北京同仁堂医养投资股份有限公司(以下简称“同仁堂医养”)上市聆讯获通过，公司将登陆港交所主板上市，独家保荐人为中金公司。公开数据显示，同仁堂医养是同仁堂 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251009/c671596860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["600085","BK0012","BK0188","LU1688375341.USD","BK0183","BK0028","BK0239","BK0113","BK0097","BK0086","BK0196"],"gpt_icon":0},{"id":"2572780559","title":"同仁堂新注册《沉浸式裸眼3D展示系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2572780559","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572780559?lang=zh_cn&edition=full","pubTime":"2025-10-02 01:50","pubTimestamp":1759341025,"startTime":"0","endTime":"0","summary":"证券之星消息，近日同仁堂（600085）新注册了《沉浸式裸眼3D展示系统V1.0》项目的软件著作权。今年以来同仁堂新注册软件著作权4个。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了9076.42万元，同比减1.66%。通过天眼查大数据分析，北京同仁堂股份有限公司共对外投资了19家企业，参与招投标项目302次；财产线索方面有商标信息51条，专利信息134条，著作权信息1条；此外企业还拥有行政许可127个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100200000044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0028","BK0196","BK0012","BK0086","BK0239","BK0188","600085","LU1688375341.USD","BK0183","BK0097"],"gpt_icon":0},{"id":"2571351618","title":"同仁堂新注册《中药材互动式智慧科普系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2571351618","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571351618?lang=zh_cn&edition=full","pubTime":"2025-09-30 01:59","pubTimestamp":1759168752,"startTime":"0","endTime":"0","summary":"证券之星消息，近日同仁堂（600085）新注册了《中药材互动式智慧科普系统V1.0》项目的软件著作权。今年以来同仁堂新注册软件著作权1个。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了9076.42万元，同比减1.66%。通过天眼查大数据分析，北京同仁堂股份有限公司共对外投资了19家企业，参与招投标项目302次；财产线索方面有商标信息51条，专利信息134条，著作权信息1条；此外企业还拥有行政许可127个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025093000001387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0196","BK0012","BK0188","BK0028","BK0113","LU1688375341.USD","BK0183","600085","BK0097","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766036925051,"stockEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":-0.0681},{"period":"3month","weight":-0.0689},{"period":"6month","weight":-0.0825},{"period":"1year","weight":-0.1734},{"period":"ytd","weight":-0.1864}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0256},{"period":"3month","weight":0.0101},{"period":"6month","weight":0.1519},{"period":"1year","weight":0.1514},{"period":"ytd","weight":0.1547}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京同仁堂股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"132210人(较上一季度增加21.16%)","perCapita":"10373股","listingDate":"1997-06-25","address":"北京市大兴区中关村科技园区大兴生物医药产业基地天贵大街33号","registeredCapital":"137147万元","survey":" 北京同仁堂股份有限公司的主营业务是中成药的生产与销售。公司的主要产品是安宫牛黄丸、同仁牛黄清心丸、同仁大活络丸、六味地黄丸，金匮肾气。公司“中药制造测量学关键技术与标准及软件装备应用项目”荣获中国产学研合作创新与促进奖。","listedPrice":7.08},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"同仁堂(600085)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供同仁堂(600085)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"同仁堂,600085,同仁堂股票,同仁堂股票老虎,同仁堂股票老虎国际,同仁堂行情,同仁堂股票行情,同仁堂股价,同仁堂股市,同仁堂股票价格,同仁堂股票交易,同仁堂股票购买,同仁堂股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"同仁堂(600085)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供同仁堂(600085)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}